Search - tctmd.com

Displaying 361 - 380 of 4475

Sort: Relevancy | Date

Pollution Deserves More Attention in Cardiology—and More Action

News Daily News

Pollution Deserves More Attention in Cardiology—and More Action

Yael L. Maxwell

June 03, 2024

June 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

June 01, 2024

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

News

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

Michael O'Riordan

May 30, 2024

Kidney Events High in Older Patients After HF Hospitalization

News Daily News

Kidney Events High in Older Patients After HF Hospitalization

May 30, 2024

Statins Effective For Primary Prevention in Old and Very Old

News Daily News

Statins Effective For Primary Prevention in Old and Very Old

Michael O'Riordan

May 29, 2024

TEMPO-2: Tenecteplase No Help in Mild Stroke With Proven Occlusion

News Conference News ESOC 2024

TEMPO-2: Tenecteplase No Help in Mild Stroke With Proven Occlusion

May 23, 2024

POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival

News Conference News EuroPCR 2024

POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival

Yael L. Maxwell

May 22, 2024

Thrombectomy’s Benefits in Large-Core Strokes Sustained at 1 Year: TENSION

News Conference News ESOC 2024

Thrombectomy’s Benefits in Large-Core Strokes Sustained at 1 Year: TENSION

May 22, 2024

More Trial Evidence Supports Tenecteplase for Acute Stroke Thrombolysis

News Conference News ESOC 2024

More Trial Evidence Supports Tenecteplase for Acute Stroke Thrombolysis

May 21, 2024

INTERACT4: Impact of Prehospital BP-Lowering May Depend on Acute Stroke Type

News Conference News ESOC 2024

INTERACT4: Impact of Prehospital BP-Lowering May Depend on Acute Stroke Type

May 20, 2024

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

News Conference News EuroPCR 2024

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Yael L. Maxwell

May 17, 2024

Medicare Analysis Suggests Benefit of PFO Closure Beyond Age 60

News Conference News ESOC 2024

Medicare Analysis Suggests Benefit of PFO Closure Beyond Age 60

May 17, 2024

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

News Conference News EuroPCR 2024

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

Michael O'Riordan

May 16, 2024

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

News Conference News EuroPCR 2024

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

May 16, 2024

Colchicine Misses in Secondary Stroke Prevention, but Door Not Closed Yet

News Conference News ESOC 2024

Colchicine Misses in Secondary Stroke Prevention, but Door Not Closed Yet

May 16, 2024

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

News Conference News EuroPCR 2024

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Michael O'Riordan

May 15, 2024

Income, Education Influence Post-Stroke Mortality in Sweden

News Conference News ESOC 2024

Income, Education Influence Post-Stroke Mortality in Sweden

May 15, 2024

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

News Conference News EuroPCR 2024

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

Yael L. Maxwell

May 15, 2024

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

News Conference News EuroPCR 2024

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

May 15, 2024

Debate Continues on TAVI Choice for Women With Small Annuli

News Conference News EuroPCR 2024

Debate Continues on TAVI Choice for Women With Small Annuli

Yael L. Maxwell

May 14, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.